• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与滥用甲状腺激素相关的猝死。

Sudden death associated with thyroid hormone abuse.

作者信息

Bhasin S, Wallace W, Lawrence J B, Lesch M

出版信息

Am J Med. 1981 Nov;71(5):887-90. doi: 10.1016/0002-9343(81)90392-2.

DOI:10.1016/0002-9343(81)90392-2
PMID:7304660
Abstract

Three patients with hyperthyroidism due to deliberate intake of excessive amounts of L-thyroxine are described wherein death was "instantaneous" and presumably due to ventricular fibrillation. Hyperthyroidism was not recognized on admission in two of these patients because of atypical presentations. Autopsy was performed in two patients. In one patient no coronary disease was present and focal myocarditis with leukocytic infiltration was noted. The second patient had an acute posterior myocardial infarction due to acute coronary thrombosis, but focal areas of leukocytic infiltration and fibrosis were also seen in the anterior wall not involved in the process of infarction. Factitious hyperthyroidism due to L-thyroxine abuse can be associated with sudden death in the absence of coronary artery disease and may be related to a drug induced myocarditis.

摘要

本文描述了3例因故意过量摄入左甲状腺素导致甲状腺功能亢进的患者,其死亡为“瞬间性”,推测是由于心室颤动所致。其中2例患者入院时因表现不典型未被诊断为甲状腺功能亢进。2例患者进行了尸检。1例患者无冠状动脉疾病,但发现有局灶性心肌炎伴白细胞浸润。第2例患者因急性冠状动脉血栓形成导致急性后壁心肌梗死,但在前壁未发生梗死的区域也可见到局灶性白细胞浸润和纤维化。滥用左甲状腺素所致的人为性甲状腺功能亢进可在无冠状动脉疾病的情况下与猝死相关,可能与药物性心肌炎有关。

相似文献

1
Sudden death associated with thyroid hormone abuse.与滥用甲状腺激素相关的猝死。
Am J Med. 1981 Nov;71(5):887-90. doi: 10.1016/0002-9343(81)90392-2.
2
Pathology of the heart in sudden cardiac death.心脏性猝死的心脏病理学
Am J Cardiol. 1977 May 26;39(6):865-72. doi: 10.1016/s0002-9149(77)80041-6.
3
[Pathological study of unexpected sudden death clustered in family or village in Yunnan province: report of 29 cases of autopsy].云南省家族或村寨聚集性不明原因猝死的病理学研究:29例尸检报告
Zhonghua Yi Xue Za Zhi. 2007 Aug 21;87(31):2209-14.
4
[Pathology of the myocardium and coronary vessels in sudden cardiac death. A post-mortem study of 130 cases].
Minerva Med. 1988 May;79(5):373-8.
5
[Immuno-morphologic diagnosis of acute ischemia and early stages of myocardial necrosis in sudden coronary death].
Arkh Patol. 1988;50(11):23-8.
6
Current concepts of coronary thrombosis as related to atherosclerosis and myocardial infarction.
Adv Exp Med Biol. 1977;82:86-93. doi: 10.1007/978-1-4613-4220-5_8.
7
Sudden unexpected death resulting from an anomalous hypoplastic left coronary artery.异常左冠状动脉发育不全导致的意外猝死。
J Forensic Sci. 1998 May;43(3):708-11.
8
Post-mortem findings of cardiac lesions in epileptics: a preliminary report.
Forensic Sci. 1976 Jul-Aug;8(1):63-71. doi: 10.1016/0300-9432(76)90048-0.
9
[A case of sudden death from a muscle bridge spanning the anterior interventricular branch of the left coronary artery].[一例因横跨左冠状动脉前室间支的肌桥导致猝死的病例]
Arkh Patol. 1988;50(10):67-9.
10
[Sudden heart death in a long distance runner during a marathon].[一名长跑运动员在马拉松比赛中突发心脏性猝死]
Z Kardiol. 1989 Apr;78(4):276-80.

引用本文的文献

1
Signaling pathways in obesity: mechanisms and therapeutic interventions.肥胖症中的信号通路:机制与治疗干预。
Signal Transduct Target Ther. 2022 Aug 28;7(1):298. doi: 10.1038/s41392-022-01149-x.
2
Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge.甲状腺激素滥用在精英运动中的监管挑战。
J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3562-e3573. doi: 10.1210/clinem/dgac223.
3
The Dark Side of hormone prescription.激素处方的阴暗面。
Endocr Connect. 2021 Aug 26;10(9):C1-C3. doi: 10.1530/EC-21-0039.
4
Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects.神经化学调节因子在食物行为治疗肥胖症中的作用:现状与未来前景。
Future Med Chem. 2020 Oct;12(20):1865-1884. doi: 10.4155/fmc-2019-0361. Epub 2020 Oct 12.
5
Thyroid hormone misuse and abuse.甲状腺激素滥用
Endocrine. 2019 Oct;66(1):79-86. doi: 10.1007/s12020-019-02045-1. Epub 2019 Oct 15.
6
Non-Thyroidal Illness Syndrome in Critically Ill Children: Prognostic Value and Impact of Nutritional Management.危重症患儿中的非甲状腺病态综合征:营养管理的预后价值和影响。
Thyroid. 2019 Apr;29(4):480-492. doi: 10.1089/thy.2018.0420. Epub 2019 Mar 11.
7
Impact of concomitant medications on obstructive sleep apnoea.合并用药对阻塞性睡眠呼吸暂停的影响。
Br J Clin Pharmacol. 2017 Apr;83(4):688-708. doi: 10.1111/bcp.13153. Epub 2016 Nov 24.
8
New advances in models and strategies for developing anti-obesity drugs.新型肥胖症治疗药物模型和策略的新进展。
Expert Opin Drug Discov. 2013 Jun;8(6):655-71. doi: 10.1517/17460441.2013.792804. Epub 2013 Apr 29.
9
Obesity pharmacotherapy: what is next?肥胖症药物治疗:下一步是什么?
Mol Aspects Med. 2013 Feb;34(1):71-83. doi: 10.1016/j.mam.2012.10.005. Epub 2012 Oct 24.
10
Obesity pharmacotherapy: current perspectives and future directions.肥胖症药物治疗:当前观点与未来方向。
Curr Cardiol Rev. 2013 Feb 1;9(1):33-54. doi: 10.2174/157340313805076322.